Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201
about
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionDetection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens.Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease.The natural history of maternal immunization against foetal platelet alloantigens.The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura.Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry.The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.Low-dose prednisone and immunoglobulin G treatment for woman at risk for neonatal alloimmune thrombocytopenia and T helper 1 immunity.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study.Post-transfusion purpura: a survey of 12 Danish cases with special reference to immunoglobulin G subclasses of the platelet antibodies.Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia.Evaluation of serological platelet antibody assays.Screening programmes for foetomaternal alloimmune thrombocytopenia.Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonateRed blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.HLA-DRB1 polymorphism is associated with Kell immunisation.Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial.Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational studyHLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.
P2860
Q26777281-810FB5D2-6637-4AFC-B1EB-0F9F7B5668EEQ33334207-45A70275-C7C8-4E84-BF98-A1793828EE57Q33360549-37777E89-CB87-40EB-A59F-F209757A8110Q33363890-F0ACDE4E-20B0-48CB-A4B4-E038DF5E1804Q33376320-29416774-E6FE-4126-8653-415990135091Q33392621-AE352DCE-7799-49CD-BD77-E22EC61ECA5DQ33392862-172068C5-9F4E-4B81-B320-BEA18375EA93Q33395614-B21BB78D-C762-4F8B-8F18-6BC85F5E0C17Q33398407-FD98EE2C-2A7F-4E1E-AFBE-1C997D2B772EQ33399783-75B73249-F67A-40A0-8A7D-7942654BEE56Q33401637-AB6C89B2-FC01-4792-8E93-252AE9DC014FQ33403500-E9C23B7C-9AB4-4DE7-94F4-9773EBD2E3A3Q33405694-DCDB5B66-4B06-4C3E-B3D9-F462DF66BDF5Q33411662-3FE09152-C176-43F1-9C22-A4209ECD0D4AQ33426745-8CED7521-FAA3-46CE-AC02-1DD7874E560AQ33435753-DFABE699-1E09-46B1-83A9-EBB2F7AA8EF2Q33436061-0B8A0D32-3F9F-4FA4-B903-13D3DB0F3C9CQ33437901-DE5FCCCF-C75B-4F0E-A25A-37ABCD0A28A1Q33439666-31557556-9B37-42A6-974A-EA5862375676Q33441520-5268FA28-8712-47D9-9C1D-A9D4B77807E6Q33489976-439974A4-6622-4558-A89C-3AAA8C90186CQ33491554-03F84378-F4AD-4DFC-BDEF-97F10FA35672Q33497352-E207F10E-44E8-41D0-A6F7-6C07EF72BDF2Q33503325-58852027-4BB5-4F0C-9EA9-5F76F5A272CBQ33503330-8097FC8E-C621-4F42-8368-FF16F95327CFQ35599094-428FFB62-1CA3-4CE3-9326-363F61D2A791Q36106307-62577D14-B7B0-4733-9910-2468E0A11EEBQ38316862-E79D8D74-1895-4273-9258-799BF092B681Q38599473-8853F04D-44F4-407F-8848-363C78656F3EQ41512544-6BB8E51E-75F7-43BC-A879-73CF7BB6EFD3Q50476222-990678FE-EA7F-4248-AD98-4C1ECEDA3220
P2860
Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@ast
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@en
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@nl
type
label
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@ast
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@en
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@nl
prefLabel
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@ast
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@en
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@nl
P2093
P1433
P1476
Alloimmunization to platelet a ...... LA-DRB3*0101 and HLA-DQB1*0201
@en
P2093
L Tremblay
P Chartrand
P304
P356
10.1016/0198-8859(92)90036-M
P407
P577
1992-06-01T00:00:00Z